Ulcerative Colitis Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Biologics, Corticosteroids, Immunomodulators 5-aminosalicylic acid, Immunosuppressant, Biosimilars, Others); Administration (Oral, Injectable); Application (Proctosigmoiditis, Ulcerative proctitis, Pancolitis Left-sided colitis, Acute severe ulcerative colitis)
Report Code: TIPRE00019336 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ulcerative Colitis Drugs Market - By Drug Type
1.3.2 Ulcerative Colitis Drugs Market - By Route of Administration
1.3.3 Ulcerative Colitis Drugs Market - By Application
1.3.4 Ulcerative Colitis Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ULCERATIVE COLITIS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ULCERATIVE COLITIS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ULCERATIVE COLITIS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ULCERATIVE COLITIS DRUGS - GLOBAL MARKET OVERVIEW
6.2. ULCERATIVE COLITIS DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIOLOGICS
7.3.1. Overview
7.3.2. Biologics Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. IMMUNOMODULATORS 5-AMINOSALICYLIC ACID
7.5.1. Overview
7.5.2. Immunomodulators 5-aminosalicylic acid Market Forecast and Analysis
7.6. IMMUNOSUPPRESSANT
7.6.1. Overview
7.6.2. Immunosuppressant Market Forecast and Analysis
7.7. BIOSIMILARS
7.7.1. Overview
7.7.2. Biosimilars Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
9. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PROCTOSIGMOIDITIS
9.3.1. Overview
9.3.2. Proctosigmoiditis Market Forecast and Analysis
9.4. ULCERATIVE PROCTITIS
9.4.1. Overview
9.4.2. Ulcerative proctitis Market Forecast and Analysis
9.5. PANCOLITIS LEFT-SIDED COLITIS
9.5.1. Overview
9.5.2. Pancolitis Left-sided colitis Market Forecast and Analysis
9.6. ACUTE SEVERE ULCERATIVE COLITIS
9.6.1. Overview
9.6.2. Acute severe ulcerative colitis Market Forecast and Analysis
10. ULCERATIVE COLITIS DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Ulcerative Colitis Drugs Market Overview
10.1.2 North America Ulcerative Colitis Drugs Market Forecasts and Analysis
10.1.3 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.1.4 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.1.6 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Ulcerative Colitis Drugs Market
10.1.6.1.1 United States Ulcerative Colitis Drugs Market by Drug Type
10.1.6.1.2 United States Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.1.3 United States Ulcerative Colitis Drugs Market by Application
10.1.6.2 Canada Ulcerative Colitis Drugs Market
10.1.6.2.1 Canada Ulcerative Colitis Drugs Market by Drug Type
10.1.6.2.2 Canada Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.2.3 Canada Ulcerative Colitis Drugs Market by Application
10.1.6.3 Mexico Ulcerative Colitis Drugs Market
10.1.6.3.1 Mexico Ulcerative Colitis Drugs Market by Drug Type
10.1.6.3.2 Mexico Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.3.3 Mexico Ulcerative Colitis Drugs Market by Application
10.2. EUROPE
10.2.1 Europe Ulcerative Colitis Drugs Market Overview
10.2.2 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis
10.2.3 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.2.6 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Ulcerative Colitis Drugs Market
10.2.6.1.1 Germany Ulcerative Colitis Drugs Market by Drug Type
10.2.6.1.2 Germany Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.1.3 Germany Ulcerative Colitis Drugs Market by Application
10.2.6.2 France Ulcerative Colitis Drugs Market
10.2.6.2.1 France Ulcerative Colitis Drugs Market by Drug Type
10.2.6.2.2 France Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.2.3 France Ulcerative Colitis Drugs Market by Application
10.2.6.3 Italy Ulcerative Colitis Drugs Market
10.2.6.3.1 Italy Ulcerative Colitis Drugs Market by Drug Type
10.2.6.3.2 Italy Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.3.3 Italy Ulcerative Colitis Drugs Market by Application
10.2.6.4 Spain Ulcerative Colitis Drugs Market
10.2.6.4.1 Spain Ulcerative Colitis Drugs Market by Drug Type
10.2.6.4.2 Spain Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.4.3 Spain Ulcerative Colitis Drugs Market by Application
10.2.6.5 United Kingdom Ulcerative Colitis Drugs Market
10.2.6.5.1 United Kingdom Ulcerative Colitis Drugs Market by Drug Type
10.2.6.5.2 United Kingdom Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Ulcerative Colitis Drugs Market by Application
10.2.6.6 Rest of Europe Ulcerative Colitis Drugs Market
10.2.6.6.1 Rest of Europe Ulcerative Colitis Drugs Market by Drug Type
10.2.6.6.2 Rest of Europe Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Ulcerative Colitis Drugs Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Ulcerative Colitis Drugs Market Overview
10.3.2 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Ulcerative Colitis Drugs Market
10.3.6.1.1 Australia Ulcerative Colitis Drugs Market by Drug Type
10.3.6.1.2 Australia Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.1.3 Australia Ulcerative Colitis Drugs Market by Application
10.3.6.2 China Ulcerative Colitis Drugs Market
10.3.6.2.1 China Ulcerative Colitis Drugs Market by Drug Type
10.3.6.2.2 China Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.2.3 China Ulcerative Colitis Drugs Market by Application
10.3.6.3 India Ulcerative Colitis Drugs Market
10.3.6.3.1 India Ulcerative Colitis Drugs Market by Drug Type
10.3.6.3.2 India Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.3.3 India Ulcerative Colitis Drugs Market by Application
10.3.6.4 Japan Ulcerative Colitis Drugs Market
10.3.6.4.1 Japan Ulcerative Colitis Drugs Market by Drug Type
10.3.6.4.2 Japan Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.4.3 Japan Ulcerative Colitis Drugs Market by Application
10.3.6.5 South Korea Ulcerative Colitis Drugs Market
10.3.6.5.1 South Korea Ulcerative Colitis Drugs Market by Drug Type
10.3.6.5.2 South Korea Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.5.3 South Korea Ulcerative Colitis Drugs Market by Application
10.3.6.6 Rest of Asia-Pacific Ulcerative Colitis Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Ulcerative Colitis Drugs Market Overview
10.4.2 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Ulcerative Colitis Drugs Market
10.4.6.1.1 South Africa Ulcerative Colitis Drugs Market by Drug Type
10.4.6.1.2 South Africa Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.1.3 South Africa Ulcerative Colitis Drugs Market by Application
10.4.6.2 Saudi Arabia Ulcerative Colitis Drugs Market
10.4.6.2.1 Saudi Arabia Ulcerative Colitis Drugs Market by Drug Type
10.4.6.2.2 Saudi Arabia Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Ulcerative Colitis Drugs Market by Application
10.4.6.3 U.A.E Ulcerative Colitis Drugs Market
10.4.6.3.1 U.A.E Ulcerative Colitis Drugs Market by Drug Type
10.4.6.3.2 U.A.E Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Ulcerative Colitis Drugs Market by Application
10.4.6.4 Rest of Middle East and Africa Ulcerative Colitis Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Ulcerative Colitis Drugs Market Overview
10.5.2 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis
10.5.3 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.5.6 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Ulcerative Colitis Drugs Market
10.5.6.1.1 Brazil Ulcerative Colitis Drugs Market by Drug Type
10.5.6.1.2 Brazil Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.1.3 Brazil Ulcerative Colitis Drugs Market by Application
10.5.6.2 Argentina Ulcerative Colitis Drugs Market
10.5.6.2.1 Argentina Ulcerative Colitis Drugs Market by Drug Type
10.5.6.2.2 Argentina Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.2.3 Argentina Ulcerative Colitis Drugs Market by Application
10.5.6.3 Rest of South and Central America Ulcerative Colitis Drugs Market
10.5.6.3.1 Rest of South and Central America Ulcerative Colitis Drugs Market by Drug Type
10.5.6.3.2 Rest of South and Central America Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Ulcerative Colitis Drugs Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ULCERATIVE COLITIS DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ULCERATIVE COLITIS DRUGS MARKET, KEY COMPANY PROFILES
13.1. BAUSCH HEALTH COMPANIES INC. (SALIX PHARMACEUTICAL)
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBVIE INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. JOHNSON AND JOHNSON
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BOEHRINGER INGELHEIM GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK AND CO
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. TEVA PHARMACEUTICALS LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TAKEDA PHARMACEUTICALS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SHIRE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PFIZER INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ulcerative Colitis Drugs Market - By Drug Type
1.3.2 Ulcerative Colitis Drugs Market - By Route of Administration
1.3.3 Ulcerative Colitis Drugs Market - By Application
1.3.4 Ulcerative Colitis Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ULCERATIVE COLITIS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ULCERATIVE COLITIS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ULCERATIVE COLITIS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ULCERATIVE COLITIS DRUGS - GLOBAL MARKET OVERVIEW
6.2. ULCERATIVE COLITIS DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIOLOGICS
7.3.1. Overview
7.3.2. Biologics Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. IMMUNOMODULATORS 5-AMINOSALICYLIC ACID
7.5.1. Overview
7.5.2. Immunomodulators 5-aminosalicylic acid Market Forecast and Analysis
7.6. IMMUNOSUPPRESSANT
7.6.1. Overview
7.6.2. Immunosuppressant Market Forecast and Analysis
7.7. BIOSIMILARS
7.7.1. Overview
7.7.2. Biosimilars Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
9. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PROCTOSIGMOIDITIS
9.3.1. Overview
9.3.2. Proctosigmoiditis Market Forecast and Analysis
9.4. ULCERATIVE PROCTITIS
9.4.1. Overview
9.4.2. Ulcerative proctitis Market Forecast and Analysis
9.5. PANCOLITIS LEFT-SIDED COLITIS
9.5.1. Overview
9.5.2. Pancolitis Left-sided colitis Market Forecast and Analysis
9.6. ACUTE SEVERE ULCERATIVE COLITIS
9.6.1. Overview
9.6.2. Acute severe ulcerative colitis Market Forecast and Analysis
10. ULCERATIVE COLITIS DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Ulcerative Colitis Drugs Market Overview
10.1.2 North America Ulcerative Colitis Drugs Market Forecasts and Analysis
10.1.3 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.1.4 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.1.6 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Ulcerative Colitis Drugs Market
10.1.6.1.1 United States Ulcerative Colitis Drugs Market by Drug Type
10.1.6.1.2 United States Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.1.3 United States Ulcerative Colitis Drugs Market by Application
10.1.6.2 Canada Ulcerative Colitis Drugs Market
10.1.6.2.1 Canada Ulcerative Colitis Drugs Market by Drug Type
10.1.6.2.2 Canada Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.2.3 Canada Ulcerative Colitis Drugs Market by Application
10.1.6.3 Mexico Ulcerative Colitis Drugs Market
10.1.6.3.1 Mexico Ulcerative Colitis Drugs Market by Drug Type
10.1.6.3.2 Mexico Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.3.3 Mexico Ulcerative Colitis Drugs Market by Application
10.2. EUROPE
10.2.1 Europe Ulcerative Colitis Drugs Market Overview
10.2.2 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis
10.2.3 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.2.6 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Ulcerative Colitis Drugs Market
10.2.6.1.1 Germany Ulcerative Colitis Drugs Market by Drug Type
10.2.6.1.2 Germany Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.1.3 Germany Ulcerative Colitis Drugs Market by Application
10.2.6.2 France Ulcerative Colitis Drugs Market
10.2.6.2.1 France Ulcerative Colitis Drugs Market by Drug Type
10.2.6.2.2 France Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.2.3 France Ulcerative Colitis Drugs Market by Application
10.2.6.3 Italy Ulcerative Colitis Drugs Market
10.2.6.3.1 Italy Ulcerative Colitis Drugs Market by Drug Type
10.2.6.3.2 Italy Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.3.3 Italy Ulcerative Colitis Drugs Market by Application
10.2.6.4 Spain Ulcerative Colitis Drugs Market
10.2.6.4.1 Spain Ulcerative Colitis Drugs Market by Drug Type
10.2.6.4.2 Spain Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.4.3 Spain Ulcerative Colitis Drugs Market by Application
10.2.6.5 United Kingdom Ulcerative Colitis Drugs Market
10.2.6.5.1 United Kingdom Ulcerative Colitis Drugs Market by Drug Type
10.2.6.5.2 United Kingdom Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Ulcerative Colitis Drugs Market by Application
10.2.6.6 Rest of Europe Ulcerative Colitis Drugs Market
10.2.6.6.1 Rest of Europe Ulcerative Colitis Drugs Market by Drug Type
10.2.6.6.2 Rest of Europe Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Ulcerative Colitis Drugs Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Ulcerative Colitis Drugs Market Overview
10.3.2 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Ulcerative Colitis Drugs Market
10.3.6.1.1 Australia Ulcerative Colitis Drugs Market by Drug Type
10.3.6.1.2 Australia Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.1.3 Australia Ulcerative Colitis Drugs Market by Application
10.3.6.2 China Ulcerative Colitis Drugs Market
10.3.6.2.1 China Ulcerative Colitis Drugs Market by Drug Type
10.3.6.2.2 China Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.2.3 China Ulcerative Colitis Drugs Market by Application
10.3.6.3 India Ulcerative Colitis Drugs Market
10.3.6.3.1 India Ulcerative Colitis Drugs Market by Drug Type
10.3.6.3.2 India Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.3.3 India Ulcerative Colitis Drugs Market by Application
10.3.6.4 Japan Ulcerative Colitis Drugs Market
10.3.6.4.1 Japan Ulcerative Colitis Drugs Market by Drug Type
10.3.6.4.2 Japan Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.4.3 Japan Ulcerative Colitis Drugs Market by Application
10.3.6.5 South Korea Ulcerative Colitis Drugs Market
10.3.6.5.1 South Korea Ulcerative Colitis Drugs Market by Drug Type
10.3.6.5.2 South Korea Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.5.3 South Korea Ulcerative Colitis Drugs Market by Application
10.3.6.6 Rest of Asia-Pacific Ulcerative Colitis Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Ulcerative Colitis Drugs Market Overview
10.4.2 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Ulcerative Colitis Drugs Market
10.4.6.1.1 South Africa Ulcerative Colitis Drugs Market by Drug Type
10.4.6.1.2 South Africa Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.1.3 South Africa Ulcerative Colitis Drugs Market by Application
10.4.6.2 Saudi Arabia Ulcerative Colitis Drugs Market
10.4.6.2.1 Saudi Arabia Ulcerative Colitis Drugs Market by Drug Type
10.4.6.2.2 Saudi Arabia Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Ulcerative Colitis Drugs Market by Application
10.4.6.3 U.A.E Ulcerative Colitis Drugs Market
10.4.6.3.1 U.A.E Ulcerative Colitis Drugs Market by Drug Type
10.4.6.3.2 U.A.E Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Ulcerative Colitis Drugs Market by Application
10.4.6.4 Rest of Middle East and Africa Ulcerative Colitis Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Ulcerative Colitis Drugs Market Overview
10.5.2 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis
10.5.3 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.5.6 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Ulcerative Colitis Drugs Market
10.5.6.1.1 Brazil Ulcerative Colitis Drugs Market by Drug Type
10.5.6.1.2 Brazil Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.1.3 Brazil Ulcerative Colitis Drugs Market by Application
10.5.6.2 Argentina Ulcerative Colitis Drugs Market
10.5.6.2.1 Argentina Ulcerative Colitis Drugs Market by Drug Type
10.5.6.2.2 Argentina Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.2.3 Argentina Ulcerative Colitis Drugs Market by Application
10.5.6.3 Rest of South and Central America Ulcerative Colitis Drugs Market
10.5.6.3.1 Rest of South and Central America Ulcerative Colitis Drugs Market by Drug Type
10.5.6.3.2 Rest of South and Central America Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Ulcerative Colitis Drugs Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ULCERATIVE COLITIS DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ULCERATIVE COLITIS DRUGS MARKET, KEY COMPANY PROFILES
13.1. BAUSCH HEALTH COMPANIES INC. (SALIX PHARMACEUTICAL)
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBVIE INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. JOHNSON AND JOHNSON
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BOEHRINGER INGELHEIM GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK AND CO
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. TEVA PHARMACEUTICALS LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TAKEDA PHARMACEUTICALS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SHIRE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PFIZER INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Bausch Health Companies Inc. (Salix Pharmaceutical)
2. AbbVie Inc.
3. Johnson and Johnson
4. Boehringer Ingelheim GmbH
5. Novartis AG
6. Merck & Co.
7. Teva Pharmaceuticals Ltd.
8. Takeda Pharmaceuticals
9. Shire
10. Pfizer Inc.
1. Bausch Health Companies Inc. (Salix Pharmaceutical)
2. AbbVie Inc.
3. Johnson and Johnson
4. Boehringer Ingelheim GmbH
5. Novartis AG
6. Merck & Co.
7. Teva Pharmaceuticals Ltd.
8. Takeda Pharmaceuticals
9. Shire
10. Pfizer Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount